PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System
NCT: NCT06133387 · RECRUITING
Brief Summary
The objective of this study is to evaluate the safety and effectiveness of the Endoluminal Surgical (ELS) System in subjects undergoing specified transanal endoluminal procedures in the rectum and sigmoid colon. Subjects will undergo endoscopic submucosal dissection (ESD), with or without closure at the discretion of the Investigator, of benign lesions in the rectum and sigmoid colon. The safety and effectiveness outcomes will be assessed intraoperatively and postoperatively at discharge and Days 7 and 30.
Frequently Asked Questions
What is PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System?
PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System is a clinical trial registered under NCT06133387. Current status: RECRUITING.
What is the status of NCT06133387?
The current status of NCT06133387 (PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System) is: RECRUITING.
When did PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System start?
PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System started on 2025-05-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.